Discovery and Development of Fatty Acid Amide Hydrolase (FAAH) Inhibitors

ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTDiscovery and Development of Fatty Acid Amide Hydrolase (FAAH) InhibitorsMark Seierstad and J. Guy Breitenbucher*View Author Information Johnson & Johnson Pharmaceutical Research and Development, L.L.C., 3210 Merryfield Row, San Diego, California 92121* To whom correspondence should be addressed. Phone: 858-784-3036. Fax: 858-784-3116. E-mail: email protectedCite this: J. Med. Chem. 2008, 51, 23, 7327–7343Publication Date (Web):November 5, 2008Publication History Received19 March 2008Published online5 November 2008Published inissue 11 December 2008https://pubs.acs.org/doi/10.1021/jm800311khttps://doi.org/10.1021/jm800311kreview-articleACS PublicationsCopyright © 2008 American Chemical SocietyRequest reuse permissionsArticle Views4972Altmetric-Citations150LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Inhibition,Inhibitors,Ketones,Peptides and proteins,Rodent models Get e-Alerts